Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp
Status:
Completed
Trial end date:
2017-12-22
Target enrollment:
Participant gender:
Summary
In this study, the activity, safety, and pharmacokinetics (PK) of KX2-391 Ointment was
evaluated in adult participants with a clinical diagnosis of stable, clinically typical
actinic keratosis (AK) on the face or scalp.